Markets › LSE › RUA.L

RUA Life Sciences plc

LSE:RUA.LHealthcareFTSE:AXX

——At close · Market cap — · Next earnings Mon 25 Jan

Ratio	FY2022	FY2023	FY2023	FY2024	FY2025	FY2025	Current · undated	YoY
Gross margin	65.8%	64.4%	78.3%	77.1%	—	68.6%	—	—
Operating margin	−105.8%	—	−88.4%	−24.0%	—	−18.5%	−18.5%	+0.0 pts
Net margin	−91.9%	−65.7%	−65.7%	0.0%	—	−3.3%	−3.3%	+0.0 pts
EBITDA margin	−89.4%	−74.1%	−71.8%	9.7%	—	−8.6%	—	—
Return on equity	−42.8%	—	−20.1%	0.0%	—	—	—	—
Return on assets	−35.4%	−17.6%	−17.6%	0.0%	—	—	—	—
Return on capital employed	−43.9%	—	−25.4%	−12.1%	—	—	—	—
Debt / equity	0.1×	—	0.1×	0.1×	0.1×	—	—	—
Debt / assets	8.4%	4.8%	4.8%	11.1%	8.7%	—	—	—
Interest coverage	−144.1×	0.0×	−23.3×	0.0×	0.0×	0.0×	—	—
Current ratio	5.2×	—	9.0×	4.9×	4.6×	—	—	—
Quick ratio	5.0×	—	8.8×	4.2×	3.9×	—	—	—
Cash ratio	3.6×	—	7.1×	3.2×	2.8×	—	—	—
Asset turnover	0.4×	0.3×	0.3×	0.4×	—	—	—	—
Inventory turnover	9.2×	—	4.2×	1.2×	—	—	—	—
Receivables turnover	3.7×	—	4.1×	3.8×	—	—	—	—
Dividend payout	0.0%	—	0.0%	0.0%	—	—	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.